Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.

S100A11 is a calcium-binding protein implicated in a variety of biologic functions such as proliferation and differentiation as well as in cancer. To further understand its role in prostate cancer, we performed immunohistochemistry on a series of benign, premalignant, malignant and metastatic prosta...

書誌詳細
主要な著者:	Rehman, I, Azzouzi, A, Cross, S, Deloulme, J, Catto, J, Wylde, N, Larre, S, Champigneuille, J, Hamdy, F
フォーマット:	Journal article
言語:	English
出版事項:	2004

類似資料

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
著者:: Rehman, I, 等
出版事項: (2003)

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
著者:: Rehman, I, 等
出版事項: (2004)

Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.
著者:: Cross, S, 等
出版事項: (2005)

S100A11 protein is overexpressed in common human cancers with spatial translocation from the nucleus to cytoplasm
著者:: Cross, S, 等
出版事項: (2004)

Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis
著者:: Lucie Andrés Cerezo, 等
出版事項: (2017-04-01)

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
著者:: Rehman, I, 等
出版事項: (2005)

S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils
著者:: Adéla Navrátilová, 等
出版事項: (2021-03-01)

Clinically localised prostate cancer is microsatellite stable.
著者:: Azzouzi, A, 等
出版事項: (2007)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
著者:: Rehman, I, 等
出版事項: (2004)

DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer.
著者:: Rehman, I, 等
出版事項: (2007)

Tissue microarray immunohistochemistry and cluster analysis confirms the validity of candidate proteins in prostate cancer identified by proteomic analysis of urine
著者:: Rehman, I, 等
出版事項: (2005)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
著者:: Rehman, I, 等
出版事項: (2004)

Prostate cancer proteomics: The urgent need for clinically validated biomarkers
著者:: Evans, C, 等
出版事項: (2009)

The use of proteomics in urological research
著者:: Rehman, I, 等
出版事項: (2005)

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.
著者:: Leiblich, A, 等
出版事項: (2006)

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer
著者:: Catto, J, 等
出版事項: (2006)

Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A.
著者:: Leiblich, A, 等
出版事項: (2007)

Gli1 appears to be constitutively expressed in the lumenal epithelial cells of the prostate but not in the basal cell layer or the mesenchyme
著者:: Spencer, A, 等
出版事項: (2004)

S100A9 protein is overexpressed in human breast and squamous cell cancers
著者:: Cross, S, 等
出版事項: (2004)

Three dimensional ultrasound and prostate cancer.
著者:: Mehta, S, 等
出版事項: (2004)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
著者:: Rehman, I, 等
出版事項: (2008)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
著者:: Glen, A, 等
出版事項: (2008)

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation
著者:: Cross, S, 等
出版事項: (2005)

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas
著者:: Ahmad, M, 等
出版事項: (2003)

PROLIFERATIVE INFLAMMATORY ATROPHY: POTENTIAL PRECURSOR LESION FOR PROSTATIC ADENOCARCINOMA
著者:: Benedetti-Padrón Inés, 等
出版事項: (2014-01-01)

The expression of S100A6 protein in human tissues and common tumours outside the central nervous system
著者:: Cross, S, 等
出版事項: (2004)

S100A8 protein is expressed in neutrophils, macrophages, some breast cancers and some squamous cell cancers
著者:: Cross, S, 等
出版事項: (2004)

Tissue microarray immunohistochemistry for S100A2, S100A4, S100A6, S100A8, S100A9, S100B and annexin I with unsupervised cluster analysis produces a useful classification of oesophageal cancers
著者:: Clarke, L, 等
出版事項: (2005)

There is loss of expression of S100A8 and S100A9 in oesophageal squamous carcinoma
著者:: Clarke, L, 等
出版事項: (2005)

Behavior of urothelial carcinoma with respect to anatomical location.
著者:: Catto, J, 等
出版事項: (2007)

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
著者:: Catto, J, 等
出版事項: (2003)

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
著者:: Catto, J, 等
出版事項: (2005)

Expression of S100A2, S100A4, S100A6 and S100A7 in oesophageal cancers follows the pattern of expression in the tissues from which they are derived and does not show any significant association with any other clinicopathological parameters
著者:: Clarke, L, 等
出版事項: (2005)

Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
著者:: Catto, J, 等
出版事項: (2009)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
著者:: Yates, DR, 等
出版事項: (2006)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
著者:: Yates, DR, 等
出版事項: (2006)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
著者:: Yates, DR, 等
出版事項: (2005)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
著者:: van Oers, J, 等
出版事項: (2009)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
著者:: Catto, J, 等
出版事項: (2006)

The impact of dysregulation SUMOylation on prostate cancer
著者:: Kailang Li, 等
出版事項: (2025-03-01)